Abbott Laboratories (ABT) This autumn 2024 Earnings Name Transcript


Abbott Laboratories (NYSE:ABT) This autumn 2024 Earnings Convention Name January 22, 2025 9:30 AM ET

Firm Individuals

Mike Comilla – Vice President, Investor Relations
Robert Ford – Chairman & Chief Govt Officer
Phil Boudreau – Govt Vice President, Finance & Chief Monetary Officer

Convention Name Individuals

Robbie Marcus – JPMorgan
Larry Biegelsen – Wells Fargo
Travis Steed – BofA Securities
Vijay Kumar – Evercore ISI
Josh Jennings – TD Cowen
David Roman – Goldman Sachs
Joanne Wuensch – Citi
Danielle Antalffy – UBS
Matt Miksic – Barclays

Operator

Good morning and thanks for standing by. Welcome to Abbott’s Fourth Quarter 2024 Earnings Convention Name. All contributors will be capable of hear solely till the question-and-answer portion of this name. [Operator Instructions] This name is being recorded by Abbott. Apart from any participant’s questions requested through the question-and-answer session, your entire name, together with the question-and-answer session, is materials copyrighted by Abbott. It can’t be recorded or rebroadcast with out Abbott’s categorical written permission.

I might now wish to introduce Mr. Mike Comilla, Vice President, Investor Relations.

Mike Comilla

Good morning and thanks for becoming a member of us. With me at this time are Robert Ford, Chairman and Chief Govt Officer; and Phil Boudreau, Govt Vice President, Finance and Chief Monetary Officer. Robert and Phil will present opening remarks. Following their feedback, we’ll take your questions.

Earlier than we get began, some statements made at this time could also be forward-looking for functions of the Non-public Securities Litigation Reform Act of 1995, together with the anticipated monetary outcomes for 2025. Abbott cautions that these forward-looking statements are topic to dangers and uncertainties that will trigger precise outcomes to vary materially from these indicated within the forward-looking statements. Financial, aggressive, governmental, technological, and different components that will have an effect on Abbott’s operations are mentioned in Merchandise 1A, Threat Elements, to our annual report on Type 10-Ok for the year-ended December 31, 2023. Abbott undertakes



Source link

Related articles

Chevron plans $7 billion Venezuela funding, targets 600,000 bpd manufacturing

(WO) — Chevron plans to speculate greater than $7 billion in Venezuela over the subsequent 5 years and greater than double manufacturing to roughly 600,000 bpd beneath new agreements that broaden the corporate's...

I discovered 5 cleansing offers value sweeping up this Labor Day

There are a variety of Labor Day vacuum offers, however loads of them are both barely discounted or simply not that fascinating. I narrowed issues down to 5 that I’d really contemplate, with...

Psychology says individuals who speak to their canines like kids aren’t being immature — people instinctively change the best way they communicate when making...

I used to be halfway via a sentence in regards to the climate after I heard myself. Pitch up round kettle vary, vowels stretched like heat toffee, the entire efficiency aimed toward a...

What the Chart Can’t Inform You: Why a Inventory Buying and selling Robotic Must Learn the Information – Buying and selling Methods – 3...

On the blind spot in each buy-the-dip technique, and what an AI module really does about it A query with no...

Kraken Guardian Pushes IPO to Q2 2027 at Earliest

Payward doesn't plan to take Kraken public earlier than the second quarter of 2027, CoinDesk reported yesterday (Wednesday), citing two folks acquainted with the matter. The corporate has a confidential draft registration assertion...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com